Total planned funding: $693,547,808
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $187,870,656 |
Uganda | $111,182,586 |
Zambia | $88,871,334 |
Mozambique | $70,676,318 |
Côte d'Ivoire | $41,404,091 |
Zimbabwe | $39,707,012 |
Kenya | $39,164,863 |
Tanzania | $27,772,045 |
Rwanda | $26,152,583 |
Vietnam | $22,175,620 |
Haiti | $15,630,710 |
Cameroon | $10,000,000 |
Democratic Republic of the Congo | $4,750,219 |
South Africa | $3,074,839 |
Burundi | $1,900,316 |
Botswana | $1,495,983 |
Guyana | $959,493 |
Eswatini | $659,961 |
Angola | $34,000 |
South Sudan | $31,572 |
India | $23,477 |
Ethiopia | $8,809 |
Cambodia | $1,321 |
Organizational Types
Private Contractor | $604,127,969 |
NGO | $79,558,889 |
Host Country Government Agency | $4,209,966 |
Own Agency | $3,416,809 |
Unknown | $2,200,000 |
FBO | $34,175 |
Implementing Agency | $0 |
Other USG Agency | $0 |
University | $0 |
Program Areas
Treatment | $693,547,808 |
Budget Codes
HTXD: Treatment: ARV Drugs | $693,547,808 |
Top Partner Programs
Medical Access Uganda Limited:
$79,320,936
View countries